Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children
Clinical trial NCT07320716 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07320716
- Sponsor
- GlaxoSmithKline
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-02
- Primary completion
- 2028-10-31
- Enrollment
- 528
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.